Viewing Study NCT00768859


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2025-12-26 @ 5:44 PM
Study NCT ID: NCT00768859
Status: COMPLETED
Last Update Posted: 2012-05-11
First Post: 2008-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module